TCBWF

0.00180.00%
LB

Lauren Bor

Head of Commercial Development Division

Dr. Lauren Bor, Ph.D. is Head of Commercial Development Division of TC Biopharm (Holdings) Plc from December 2023. Dr. Bor completed a Bsc Hons degree in Immunology from the University of Glasgow. She obtained her Ph.D in Immunobiology, titled "The Generation of MHC Class I Restricted Antigen Specific Regulatory T Cells for the treatment of Type 1 Diabetes" from Kings College London in 2014. Dr. Bor then joined the lab of Professor Waseem Qasim at University College London as a Post-Doctoral Researcher where she led the development of closed-system, automated manufacturing platforms for CAR T cells. Following successful manufacture of CD19 CAR T cells for clinical trials and scale up of gene edited CAR T cells at UCL. Lauren Joined TC BioPharm in 2019, and her area of research has been the process development and technology transfer of TC BioPharm's Unmodified cryopreserved V?9Vd2 T cell manufacturing process.

Positions